Showing results (1161-1170 of 1,416) with videos related to

Sort By:
Pageof 142
Oncotarget|August 27, 2016
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patientsGijs G Zom, Marij J P Welters, Nikki M Loof, et al.
Nature Communications|November 26, 2020
Publisher Correction: A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup AJacopo Enotarpi, Marta Tontini, Cristiana Balocchi, et al.
The Review of Scientific Instruments|November 3, 2020
Aurore: A platform for ultrafast sciencesN Fedorov, S Beaulieu, A Belsky, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
PARP1 recruits SPRTN to DNA-protein crosslinks through a conserved poly-ADP-ribose binding domainKatelyn Hurley, Liam P Leary, Martin Garcia, et al.
Nature Communications|September 8, 2020
A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup AJacopo Enotarpi, Marta Tontini, Cristiana Balocchi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical OutcomesSabrina I Green, Justin R Clark, Haroldo H Santos, et al.
ACS Chemical Biology|May 8, 2018
Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified EpitopesAnouk M F van der Gracht, Mark A R de Geus, Marcel G M Camps, et al.
Nature Communications|February 4, 2021
Laboratory disruption of scaled astrophysical outflows by a misaligned magnetic fieldG Revet, B Khiar, E Filippov, et al.
Nature Communications|May 31, 2020
Characterization of glycosyl dioxolenium ions and their role in glycosylation reactionsThomas Hansen, Hidde Elferink, Jacob M A van Hengst, et al.
Vaccine|November 9, 2004
Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour modelMarij J P Welters, Dmitri V Filippov, Susan J F van den Eeden, et al.
Pageof 142